Lazard Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,294
| Closed | -$76K | – | 2470 |
|
|
2023
Q4 | $76K | Buy |
+1,294
| New | +$76K | ﹤0.01% | 1767 |
|
|
2022
Q1 | – | Sell |
-348
| Closed | -$51K | – | 2600 |
|
|
2021
Q4 | $51K | Sell |
348
-4,287
| -92% | -$628K | ﹤0.01% | 1736 |
|
|
2021
Q3 | $819K | Buy |
+4,635
| New | +$819K | ﹤0.01% | 1098 |
|
|
2020
Q3 | – | Sell |
-19
| Closed | -$2K | – | 1773 |
|
|
2020
Q2 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 1574 |
|
|
2018
Q1 | – | Sell |
-20,383
| Closed | -$371K | – | 1137 |
|
|
2017
Q4 | $371K | Buy |
+20,383
| New | +$371K | ﹤0.01% | 806 |
|